BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 24982447)

  • 1. Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis.
    Landreneau RJ; Normolle DP; Christie NA; Awais O; Wizorek JJ; Abbas G; Pennathur A; Shende M; Weksler B; Luketich JD; Schuchert MJ
    J Clin Oncol; 2014 Aug; 32(23):2449-55. PubMed ID: 24982447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes after nonintubated versus intubated thoracoscopic lobectomy for clinical stage I non-small cell lung cancer: A propensity-matched analysis.
    Wang ML; How CH; Hung MH; Huang HH; Hsu HH; Cheng YJ; Chen JS
    J Formos Med Assoc; 2021 Nov; 120(11):1949-1956. PubMed ID: 33994233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.
    Carr SR; Schuchert MJ; Pennathur A; Wilson DO; Siegfried JM; Luketich JD; Landreneau RJ
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):390-7. PubMed ID: 22169444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lobectomy vs. segmentectomy. A propensity score matched comparison of outcomes.
    Roman M; Labbouz S; Valtzoglou V; Ciesla A; Hawari M; Addae-Boateng E; Thorpe JA; Duffy JP; Majewski A
    Eur J Surg Oncol; 2019 May; 45(5):845-850. PubMed ID: 30409440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes with segmentectomy versus lobectomy in patients with clinical T1cN0M0 non-small cell lung cancer.
    Chan EG; Chan PG; Mazur SN; Normolle DP; Luketich JD; Landreneau RJ; Schuchert MJ
    J Thorac Cardiovasc Surg; 2021 May; 161(5):1639-1648.e2. PubMed ID: 32331817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of thoracoscopic segmentectomy and thoracoscopic lobectomy on the patients with non-small cell lung cancer: a propensity score matching study.
    Hwang Y; Kang CH; Kim HS; Jeon JH; Park IK; Kim YT
    Eur J Cardiothorac Surg; 2015 Aug; 48(2):273-8. PubMed ID: 25406426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncologic Outcomes of Segmentectomy Versus Lobectomy for Clinical T1a N0 M0 Non-Small Cell Lung Cancer.
    Kodama K; Higashiyama M; Okami J; Tokunaga T; Imamura F; Nakayama T; Inoue A; Kuriyama K
    Ann Thorac Surg; 2016 Feb; 101(2):504-11. PubMed ID: 26542438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.
    Subramanian M; McMurry T; Meyers BF; Puri V; Kozower BD
    Ann Thorac Surg; 2018 Aug; 106(2):375-381. PubMed ID: 29580779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival outcomes in a prospective randomized multicenter Phase III trial comparing patients undergoing anatomical segmentectomy versus standard lobectomy for non-small cell lung cancer up to 2 cm.
    Stamatis G; Leschber G; Schwarz B; Brintrup DL; Flossdorf S; Passlick B; Hecker E; Kugler C; Eichhorn M; Krbek T; Eggeling S; Hatz R; Müller MR; Hillinger S; Aigner C; Jöckel KH
    Lung Cancer; 2022 Oct; 172():108-116. PubMed ID: 36058174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm.
    Huang CS; Hsu PK; Chen CK; Yeh YC; Hsu HS; Shih CC; Huang BS
    Thorac Cancer; 2020 Apr; 11(4):907-917. PubMed ID: 32037690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segmentectomy versus lobectomy in early non-small cell lung cancer of 2 cm or less in size: A population-based study.
    Moon MH; Moon YK; Moon SW
    Respirology; 2018 Jul; 23(7):695-703. PubMed ID: 29465766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lobectomy does not confer survival advantage over segmentectomy for non-small cell lung cancer with unsuspected nodal disease.
    Razi SS; Nguyen D; Villamizar N
    J Thorac Cardiovasc Surg; 2020 Jun; 159(6):2469-2483.e4. PubMed ID: 31928821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wedge resection versus segmentectomy in patients with stage I non-small-cell lung cancer unfit for lobectomy.
    Tsutani Y; Kagimoto A; Handa Y; Mimae T; Miyata Y; Okada M
    Jpn J Clin Oncol; 2019 Dec; 49(12):1134-1142. PubMed ID: 31602468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lobectomy versus segmentectomy: a propensity score-matched comparison of postoperative complications, pulmonary function and prognosis.
    Nomori H; Yamazaki I; Machida Y; Otsuki A; Cong Y; Sugimura H; Oyama Y
    Interact Cardiovasc Thorac Surg; 2022 Jan; 34(1):57-65. PubMed ID: 34999814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage I non-small-cell lung cancer: long-term results of lobectomy versus sublobar resection from the Polish National Lung Cancer Registry.
    Dziedzic R; Zurek W; Marjanski T; Rudzinski P; Orlowski TM; Sawicka W; Marczyk M; Polanska J; Rzyman W
    Eur J Cardiothorac Surg; 2017 Aug; 52(2):363-369. PubMed ID: 28402455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after lobectomy versus segmentectomy for stage I non-small cell lung cancer: a population-based analysis.
    Whitson BA; Groth SS; Andrade RS; Maddaus MA; Habermann EB; D'Cunha J
    Ann Thorac Surg; 2011 Dec; 92(6):1943-50. PubMed ID: 21962268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer.
    Schuchert MJ; Pettiford BL; Keeley S; D'Amato TA; Kilic A; Close J; Pennathur A; Santos R; Fernando HC; Landreneau JR; Luketich JD; Landreneau RJ
    Ann Thorac Surg; 2007 Sep; 84(3):926-32; discussion 932-3. PubMed ID: 17720401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802/WJOG4607L): a post-hoc supplemental analysis of a multicentre, open-label, phase 3 trial.
    Hattori A; Suzuki K; Takamochi K; Wakabayashi M; Sekino Y; Tsutani Y; Nakajima R; Aokage K; Saji H; Tsuboi M; Okada M; Asamura H; Nakamura K; Fukuda H; Watanabe SI; ;
    Lancet Respir Med; 2024 Feb; 12(2):105-116. PubMed ID: 38184010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncologic Outcomes of Complex Segmentectomy: A Multicenter Propensity Score-Matched Analysis.
    Handa Y; Tsutani Y; Mimae T; Miyata Y; Imai K; Ito H; Nakayama H; Ikeda N; Yoshimura K; Okada M
    Ann Thorac Surg; 2021 Mar; 111(3):1044-1051. PubMed ID: 32795524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.